Synthesis and structure-activity studies of novel benzocycloheptanone oxazolidinone antibacterial agents. 2006

J V N Vara Prasad, and Frederick E Boyer, and Lou Chupak, and Michael Dermyer, and Qizhu Ding, and K Gavardinas, and Susan E Hagen, and Michael D Huband, and Wenhua Jiao, and Takushi Kaneko, and Samarendra N Maiti, and Michael Melnick, and Karina Romero, and M Patterson, and Xiujuan Wu
Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, USA. Josyula.VaraPrasad@Pfizer.com

We describe a novel class of benzocycloheptanone derived oxazolidinone antibacterial agents. The synthesis and antibacterial activities with structure variation is discussed.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001567 Benzocycloheptenes Compounds consisting of the cycloheptene ring with one or two BENZENE rings fused to it.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D023303 Oxazolidinones Derivatives of oxazolidin-2-one. They represent an important class of synthetic antibiotic agents. 1,3-Oxazolidin-2-one,Oxazolidin-2-one,Oxazolidinone,1,3-Oxazolidine-2-one,2-Oxazolidone,2-oxazolidinone,1,3 Oxazolidin 2 one,1,3 Oxazolidine 2 one,2 Oxazolidone,2 oxazolidinone,Oxazolidin 2 one

Related Publications

J V N Vara Prasad, and Frederick E Boyer, and Lou Chupak, and Michael Dermyer, and Qizhu Ding, and K Gavardinas, and Susan E Hagen, and Michael D Huband, and Wenhua Jiao, and Takushi Kaneko, and Samarendra N Maiti, and Michael Melnick, and Karina Romero, and M Patterson, and Xiujuan Wu
November 2011, Journal of medicinal chemistry,
J V N Vara Prasad, and Frederick E Boyer, and Lou Chupak, and Michael Dermyer, and Qizhu Ding, and K Gavardinas, and Susan E Hagen, and Michael D Huband, and Wenhua Jiao, and Takushi Kaneko, and Samarendra N Maiti, and Michael Melnick, and Karina Romero, and M Patterson, and Xiujuan Wu
January 2015, Bioorganic & medicinal chemistry letters,
J V N Vara Prasad, and Frederick E Boyer, and Lou Chupak, and Michael Dermyer, and Qizhu Ding, and K Gavardinas, and Susan E Hagen, and Michael D Huband, and Wenhua Jiao, and Takushi Kaneko, and Samarendra N Maiti, and Michael Melnick, and Karina Romero, and M Patterson, and Xiujuan Wu
November 2003, Bioorganic & medicinal chemistry letters,
J V N Vara Prasad, and Frederick E Boyer, and Lou Chupak, and Michael Dermyer, and Qizhu Ding, and K Gavardinas, and Susan E Hagen, and Michael D Huband, and Wenhua Jiao, and Takushi Kaneko, and Samarendra N Maiti, and Michael Melnick, and Karina Romero, and M Patterson, and Xiujuan Wu
April 2001, Chemical & pharmaceutical bulletin,
J V N Vara Prasad, and Frederick E Boyer, and Lou Chupak, and Michael Dermyer, and Qizhu Ding, and K Gavardinas, and Susan E Hagen, and Michael D Huband, and Wenhua Jiao, and Takushi Kaneko, and Samarendra N Maiti, and Michael Melnick, and Karina Romero, and M Patterson, and Xiujuan Wu
April 2001, Chemical & pharmaceutical bulletin,
J V N Vara Prasad, and Frederick E Boyer, and Lou Chupak, and Michael Dermyer, and Qizhu Ding, and K Gavardinas, and Susan E Hagen, and Michael D Huband, and Wenhua Jiao, and Takushi Kaneko, and Samarendra N Maiti, and Michael Melnick, and Karina Romero, and M Patterson, and Xiujuan Wu
May 2011, Bioorganic & medicinal chemistry letters,
J V N Vara Prasad, and Frederick E Boyer, and Lou Chupak, and Michael Dermyer, and Qizhu Ding, and K Gavardinas, and Susan E Hagen, and Michael D Huband, and Wenhua Jiao, and Takushi Kaneko, and Samarendra N Maiti, and Michael Melnick, and Karina Romero, and M Patterson, and Xiujuan Wu
October 2008, Journal of medicinal chemistry,
J V N Vara Prasad, and Frederick E Boyer, and Lou Chupak, and Michael Dermyer, and Qizhu Ding, and K Gavardinas, and Susan E Hagen, and Michael D Huband, and Wenhua Jiao, and Takushi Kaneko, and Samarendra N Maiti, and Michael Melnick, and Karina Romero, and M Patterson, and Xiujuan Wu
April 2007, European journal of medicinal chemistry,
J V N Vara Prasad, and Frederick E Boyer, and Lou Chupak, and Michael Dermyer, and Qizhu Ding, and K Gavardinas, and Susan E Hagen, and Michael D Huband, and Wenhua Jiao, and Takushi Kaneko, and Samarendra N Maiti, and Michael Melnick, and Karina Romero, and M Patterson, and Xiujuan Wu
November 1985, Journal of medicinal chemistry,
J V N Vara Prasad, and Frederick E Boyer, and Lou Chupak, and Michael Dermyer, and Qizhu Ding, and K Gavardinas, and Susan E Hagen, and Michael D Huband, and Wenhua Jiao, and Takushi Kaneko, and Samarendra N Maiti, and Michael Melnick, and Karina Romero, and M Patterson, and Xiujuan Wu
April 2001, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!